期刊文献+

急性冠状动脉综合征患者N末端B型钠尿肽前体和肌钙蛋白Ⅰ水平与冠状动脉病变的关系 被引量:8

Correlation of NT-proBNP and cTnI with coronary lesion in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨急性冠状动脉综合征患者血清N末端B型钠尿肽前体(NT-proBNP)和肌钙蛋白I(cTnI)含量与冠状动脉病变程度的关系。方法选择急性冠状动脉综合征患者98例,分为急性ST段抬高心肌梗死(STEMI)组46例,急性非ST段抬高心肌梗死(NSTEMI)组16例,不稳定性心绞痛(UAP)组36例,均于入院时或发病24 h内测定患者血清NT-proBNP、cTnI含量,冠状动脉造影了解冠状动脉病变情况,并行心脏彩色多普勒超声检测,以评估患者的心功能。结果与UAP组比较,STEMI组和NSTEMI组NT-proBNP明显升高;与NSTEMI组比较,STEMI组cTnI明显升高(P<0.05)。NT-proBNP与冠状动脉病变积分呈正相关(r=0.156,P<0.05),与LVEF呈负相关(r=-0.196,P<0.01);cTnI与冠状动脉病变积分呈正相关(r=0.247,P<0.01)。结论急性冠状动脉综合征患者NT-proBNP与cTnI无关,但两者均可反映冠状动脉病变的严重程度。NT-proBNP的高低能反映患者的心功能状态,cTnI则与心功能无关。 Objective To study the correlation of NT-proBNP and cTnI with coronary lesion in pa- tients with acute coronary syndrome(ACS). Methods Ninety-eight ACS patients were divided in- to acute ST segment elevation myocardial infarction(STEMI) group(n=46),non ST elevation a- cute myocardial infarction(NSTEMI) group (n = 16), and unstable angina pectoris (UAP) group (n= 36). Their serum NT-proBNP and cTnI levels were measured and their coronary angiographic findings were observed at admission or within 24 hours after onset of ACS. Their cardiac function was assessed by cardiac color Doppler ultrasonography. Results The serum NT-proBNP level was significantly higher in STEMI group and NSTEMI group than in UAP group while the serum cTnI level was significantly higher in STEMI group than in NSTEMI group(P〈0.05). The ser- um NT-proBNP and cTnI levels were positively correlated with the coronary lesion score (r = 0. 156,P〈0.05 ;r=0. 247, P〈0.01) and negatively correlated with the left ventricular ejection fraction(r=-0. 196,P〈0. 01). Conclusion The serum NT-proBNP level is not correlated with the serum cTnI level in ACS patients. However, they can reflect the severity of coronary lesion. The serum N-proBNP level can reflect the cardiac function of ACS patients while the serum cTnI level cannot.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第11期1169-1172,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 急性冠状动脉综合征 肌钙蛋白Ⅰ 心肌梗死 冠状血管造影术 利钠肽 超声心动描记术 多普勒 彩色 acute coronary syndrome troponin I myocardial infarction coronary angiography na-triuretic peptide, brain echocardiography, Doppler, color
  • 相关文献

参考文献9

  • 1陆再英.钟南山.内科学.第7版.北京:人民卫生出版社,2007.794.
  • 2Birukova AA,Xing J, Fu P, et al. Atrial natriuretic peptide at- tenuates LPS-induced lung vascular leak: role of PAK1. Am J Physiol Lung Cell Mol Physiol,2010,299 :652-663.
  • 3Omland T,de Lemos JA. Amino-terminal pro-B-type natriuret ic peptides in stable and unstable ischemic heart disease. Am J Cardiol,2008,101:61-66.
  • 4Wolber T, Maeder M, Richli H, et al. N-terminal pro-brain natriuretic peptide used for prediction of coronary artery steno- sis. Eur J Clin Invest,2007,37:18-25.
  • 5赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 6彭杰成,龙明智,章海燕,徐少华,姜海.BNP、MCP-1对不稳定型心绞痛近期预后判断的价值[J].南京医科大学学报(自然科学版),2010,30(3):405-408. 被引量:9
  • 7Aylin Y, Sadik A, Cagatay E, et al. Effects of lesion complexity on haseLifie and postproeedural B-type natrluretic peptide levels in patients undergoing percutaneous coronary interventions. Tex Heart Inst J,2007,34:282-289.
  • 8苏华,周胜华,潘宏伟,等.脑钠肽对不稳定型心绞痛和(或)1FST段抬高心肌梗死患者冠状动脉病变程度的预测.临床心魄管病杂志,2008,24:117-119.
  • 9熊大迁,张爽,何勇,张灵玲.N末端脑钠肽在急性心肌梗死中的应用[J].检验医学与临床,2011,8(4):426-427. 被引量:6

二级参考文献36

  • 1曹雅旻,胡大一,闫丽.急性冠状动脉综合征严重程度与血浆氨基酸N末端脑钠肽原浓度相关性的研究[J].中华心血管病杂志,2005,33(10):899-902. 被引量:60
  • 2何奔,丁嵩,卜军,刘建平,宋玮,杜勇平,沈节艳,金叔宣,孙瑜,沈珑.脑利钠肽和C-反应蛋白在急性冠状动脉综合征介入治疗患者的预后价值[J].中华心血管病杂志,2006,34(4):349-352. 被引量:56
  • 3Weber M,Bazzino O,Navarro Estrada JL,et al. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coro- nary syndromes and normal troponin T values upon admission[J]. J Am Coil Cardiol,2008,51 (12) : 1188-1195.
  • 4de Lemos JA, Morrow DA, Blazing MA,et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes:results from the A to Z trial[J]. Am J Cardiol, 2007,50(27) : 2117-2124.
  • 5Morrow DA,de Lemos JA,Blazing MA,et al. Prognostic value of serial B-type natriuretie peptide testing during follow-up of patients with unstable coronary artery disease [J]. JAMA, 2005,294(22) : 2866-2871.
  • 6Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function [J]. Am J Cardiol,2006,98 (10) : 1322-1328.
  • 7Sinclair H,Paterson M,Walker S,et al. Predicting outcome in patients with acute coronary syndrome:evalua- tion of B-type natriuretic peptide and the global registry of acute coronary events (GRACE)risk score [J].Scott Med J,2007,52(3) :8-13.
  • 8de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J]. N Engl J Med,2001,345 (lg) : 1014-1021.
  • 9Sabatine MS,Morrow DA,de Lemos JA,et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia [J], J Am Coll Cardiol, 2004,44(10) : 1988-1995.
  • 10Asada J,Tsuji H,Iwasaka T,et al. Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine- induced myocardial ischemia [J].Am J Cardiol,2004,93 (6) :702-704.

共引文献113

同被引文献59

  • 1毛懿,杨跃进,张健,赵雪燕,倪新海,陈纪林,高润霖,陈在嘉.急性心肌梗死患者血B-型尿钠肽水平的变化特点[J].中华心血管病杂志,2006,34(5):425-428. 被引量:50
  • 2中华医学会心血管病学分会,中华心血管病杂志编辑委员会.不稳定性心绞痛诊断和治疗建议[J].中华循环杂志,2001,16(3):227.
  • 3Liu L S. Cardiovascular diseases in China[J]. Bioehem Cell Biol, 2007, 85(2): 157.
  • 4Bonello L, Sbragia P, Amabile N, et al. Protective effect of an acute oral loading dose of trimetazidine on myocardial in- jury following percutaneous coronary intervention[J ]. Heart, 2007, 93(6): 703.
  • 5Cuculi F, Lim C C, Banning A P. Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented[J]. Heart, 2010, 96 (10): 736.
  • 6Kurt I H, Demirkol S, hal I, et al. Changes in BNP, hs- CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STE- MI : a prospective observational cohort study [ J ]. Anadolu Kardiyol Derg, 2012, 12(2): 107.
  • 7Jakovljevie VLj, Djordjevic D Z, Djuric D M. The effects of vitamin C and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart[J]. Gen Physiol Biophys, 2011, 30(3) : 293.
  • 8Crea F,Liuzzo G.Pathogenesis of acute coronary syndromes[J].J Am Coll Cardiol,2013,61(1):1-11.
  • 9Filippatos G,Fannakis D,Parissis J.Novel biomarkers in acute coronary syndromes:new molecules,new concepts,but what about new treatment strategies?[J].J Am Coll Cardiol,2014,63(16):1654-1656.
  • 10徐国宾,黄燕,王蕴峰.CK及其同工酶CK-MB测定的方法学进展和临床应用[J].中华检验医学杂志,2008,31(12):1418-1421. 被引量:11

引证文献8

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部